BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2020
View Archived Issues
Unexpected mechanism, combination possibilities for CDK4/6 inhibitors
Read More
In SIV infection, gut integrity is retained, not repaired
Read More
Stromal FOXC1 and tumoral ERK1-2, p38 as prognostic biomarkers in DLBCL
Read More
A panel of markers found to distinguish thymomas from thymic carcinomas
Read More
Scale-up synthesis and characterization of a TRPV1 agonist with strong topical analgesic activity
Read More
Transplantation of NSCs overexpressing Wnt4 shows preclinical utility for spinal cord injuries
Read More
New STAT3 inhibitor inhibits tumor growth and metastasis in preclinical models of colorectal cancer
Read More
Results from first-in-human study of [11C]SMW-139 as an in vivo neuroinflammation tracer in MS
Read More
Update on clinical development of opaganib
Read More
Safety and PK data presented for GS-9722
Read More
Phase I results for rectally administered microbicide gel formulated with IQP-0528
Read More
Aberrant DNA methylation predicts survival in acral melanoma
Read More
U.S. researchers present biodegradable implant for antiretroviral contraceptive delivery
Read More
Phase III GY004 study does not meet primary endpoint
Read More
Newave Pharmaceutical patents Bcl-2 inhibitors
Read More
Phase II study of MK-1454 and pembrolizumab in HNSCC initiated
Read More
Corvus Pharmaceuticals discloses adenosine receptor modulators
Read More
CANBERRA trial to evaluate RG-7774 in diabetic retinopathy
Read More
GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection
Read More
Phase I/II trial of NEXI-001 underway in AML/MDS relapsing after hematopoietic cell transplant
Read More
Sunshine Lake Pharma discovers HBsAg inhibitors for HBV infections
Read More
New CD73 inhibitors presented by Eternity Bioscience
Read More
With Uhambo's and research lessons, once more unto the breach
Read More
